High proportion of drug hypersensitivity reactions to sulfasalazine following its use in anti-PD-1-associated inflammatory arthritis.

Ford, Mark; Sahbudin, Ilfita; Filer, Andrew; Steven, Neil; Fisher, Benjamin A

Ford, Mark; Sahbudin, Ilfita; Filer, Andrew; Steven, Neil; Fisher, Benjamin A.

Afiliação

Ford M; Rheumatology Department, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.
Sahbudin I; Rheumatology Department, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.
Filer A; Rheumatology Research Group, Arthritis Research UK Rheumatoid Arthritis Pathogenesis Centre of Excellence, Institute of Inflammation and Ageing, University of Birmingham, Birmingham, UK.
Steven N; National Institute for Health Research, Birmingham Biomedical Research Centre, Birmingham, UK.
Fisher BA; Rheumatology Department, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.

Rheumatology (Oxford) ; 57(12): 2244-2246, 2018 12 01.

Article em En | MEDLINE | ID: mdl-30107548

Assuntos

Artrite Reumatoide/tratamento farmacológico; Hipersensibilidade a Drogas/imunologia; Receptor de Morte Celular Programada 1/imunologia; Sulfassalazina/efeitos adversos; Idoso; Artrite Reumatoide/imunologia; Feminino; Humanos; Masculino; Pessoa de Meia-Idade

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Artrite Reumatoide / Sulfassalazina / Hipersensibilidade a Drogas / Receptor de Morte Celular Programada 1 Tipo de estudo: Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google